Lisa Decker, Ph.D.

As Chief Business Officer, Lisa leads the company’s business development strategy, transactions, and partnership management with companies across the pharma and biotech landscape.

Lisa brings 20+ years of experience in biotechnology leadership and building successful, high-impact biotech partnerships to Terray.Before joining in 2026, Ms. Decker was Chief Business Officer at IGM Biosciences, where she oversaw business development, alliance and program management, and intellectual property functions until its acquisition. Prior to her role at IGM Biosciences, Ms. Decker was Chief Business Officer at Atreca, Inc., where she led business development and alliance management. She joined Atreca from Nektar Therapeutics, where she had served in multiple roles spanning business strategy and operations, program leadership, and business development and alliance management. She also served on the board of directors of publicly-traded Chimerix, Inc., until its acquisition by Jazz Pharmaceuticals in 2025. Earlier in her career, Ms. Decker served as Associate Director in the Office of Technology Management at the University of Massachusetts Medical School.

Ms. Decker received her Ph.D. in Immunology from Tufts University School of Medicine and her B.A. in Biology from the College of the Holy Cross.